According to global commercial real estate consultant CBRE, U.S. commercial investor sentiment and transaction activity are recovering from the depths of the COVID-19 crisis.
CBRE is further reporting that at the end of July 2020, the number of signed confidentiality agreements was down by only 17% year-over-year--a marked improvement from the 74% drop-off in April and May 2020. This measure of revived investor interest could be a harbinger of a future rebound in commercial real estate transaction volume.
Signed confidentiality agreements in Q2 2020 for industrial and multifamily property offerings reached 46% and 42%, respectively, of the past two years' average Q2 level. Lockdown measures due to COVID-19 have spurred higher e-commerce growth, particularly online grocery shopping. Expansion of supply chains and retailers' omnichannel presence will propel continued demand for logistics facilities and warehouses.
COVID health concerns and the potential for companies to more enthusiastically embrace remote-working arrangements have weakened the rental outlook for some office properties. Operational office assets, such as life sciences facilities, data centers and single-tenant buildings, are more resistant to downturn risks and offer investors income stability. The rising popularity of operational office has buoyed total transaction levels and led to a material pick-up in the average price per sq. ft. of property sales.
Many investors are requesting price reductions, says CBRE. Property values are expected to decline 10% to 20% by year's end, causing a moderate rise in cap rates. While this trend was not fully manifested in Q2 2020 due to limited transaction activity, July sales indicate cap rates of Class-A industrial and multifamily assets were more stable in Q2 compared with other asset types.
Looking ahead, CBRE predicts an eventual recovery of transaction activity will be led by value-add investors with abundant capital and risk-averse investors seeking an alternative to low-yielding bonds, allowing cap rates to return to pre-COVID levels within three years.